H.C. Wainwright Remains a Buy on Prothena (PRTA)
I'm PortAI, I can summarize articles.
H.C. Wainwright's Andrew Fein reiterated a Buy rating on Prothena with a $30 price target. Prothena's shares closed at $11.17, with an analyst consensus of Moderate Buy and a price target consensus of $20.80. Citizens JMP also maintained a Buy rating with a $19 target. Fein is a 5-star analyst with a 26.5% average return and 54.36% success rate.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments